Healthtech startup Alodokter today (07/6) announced additional funding from MDI Ventures and Samsung Ventures Investment Corporation. The value is undisclosed and this is a follow on investment to the series C+ funding in November 2020 and series C funding in October 2019.
“Investments from MDI Ventures and Samsung Ventures will be directed towards further enhancing the Alodokter ecosystem [..] Key areas of focus going forward include technological innovation, increasing the talent pool, and adding new features and functionality. Our expansion has always focused on providing a better customer experience. fast, accurate and reliable on the Alodokter platform,” Alodokter’s Founder & CEO, Nathanael Faibis.
Based on the statistics, Alodokter is currently connected to around 43 thousand doctors and 1500 hospitals/health clinics. They have also served millions of patients in Indonesia. The services offered include health content, telemedicine, online ordering of doctor’s appointments, drug purchases, and insurance packages.
“The pandemic has driven the acceptance of telemedicine services for both patients and healthcare providers. We believe that enabling better healthcare through technology is more important than ever,” Alodokter’s Co-Founder & President Director, Suci Arumsari.
Throughout 2021, the health-tech sector has raised bigger attention due to its potential to help people gain access to health facilities. Other health-tech startups also being invested, including the rival Halodoc in April 2021 with series C funding worth IDR 1.1 trillion. Recently, Prixa also secured a seed funding worth of 40 billion Rupiah from MDI Ventures and TPFT.
“Alodokter has a proven track record in developing their comprehensive healthcare solutions. All innovations, from telemedicine to insurance, have been developed to provide Indonesian people for affordable healthcare. MDI investment will further expand healthcare growth through potential collaborations with several SOEs in Indonesia,” MDI Ventures’ CEO, Donald Wihardja said.
Since 2019, Alodokter has been supported by ranks of investors, including Softbank Ventures, Sequis, Golden Gate Ventures, Philips, Heritas, and Hera Capital.
In terms of Samsung Ventures, apart from Alodokter, they have invested in Travelio and Gojek. Meanwhile, apart from Alodokter and Prixa, MDI Ventures also invested in other healthtech startups, mClinica (Singapore), CXA Group (Singapore), and Heals Healthcare Group (Hong Kong).
–
Original article is in Indonesian, translated by Kristin Siagian